Literature DB >> 6439450

Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.

M Gobbi, F Caligaris-Cappio, D Campana, P L Tazzari, L Bergui, M Cavo, S Tura.   

Abstract

Peripheral blood B lymphocytes, depleted of adherent cells, from 10 patients with multiple myeloma were cultured in the presence of PWM with autologous or donor T lymphocytes. The results show that: (1) co-cultures with allogeneic T lymphocytes produced more plasma cells than those with autologous ones; (2) the kappa/lambda ratio overlapped the values obtained in normal controls, irrespective of the light chain produced by the neoplastic plasma cells and (3) the immunological phenotype of plasma cells obtained from PWM stimulated peripheral B cells (RFA2+, RFA3+, A10+) was clearly different from that one of myelomatous plasma cells (RFA2-, RFA3-, A10+). These data confirm the T cell imbalance already seen in myeloma patients; moreover they show that PWM responsive B cell are functionally normal and phenotypically different from bone marrow myeloma cells. These results support the view that most of the peripheral B lymphocytes, previously identified as monoclonal are in fact normal cells bearing adherent monoclonal Ig molecules.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439450      PMCID: PMC1577116     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Monocyte-mediated suppression of human B lymphocyte differentiation in vitro.

Authors:  W Knapp; G Baumgartner
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Terminal B cell development as seen in different human myelomas and related disorders.

Authors:  G F Burns; C P Worman; B E Roberts; C G Raper; C R Barker; J C Cawley
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

3.  Multiple myeloma and benign monoclonal gammopathy: differentiation by immunofluorescence of lymphocytes.

Authors:  F D Lindström; W R Hardy; B J Eberle; R C Williams
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

4.  B and T cell markers of bone marrow and peripheral blood lymphoid cells in patients with paraproteinaemia.

Authors:  S Husz; F Krizsa; A Dobozy; J Hunyadi; N Simon
Journal:  Acta Haematol       Date:  1977       Impact factor: 2.195

5.  Monoclonal lymphocyte population in human plasma cell myeloma.

Authors:  H Mellstedt; S Hammarström; G Holm
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

6.  Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin.

Authors:  D A Horwitz; P I Lobo
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

7.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

8.  Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease.

Authors:  F Lauria; R Foa; M Cavo; M Gobbi; D Raspadori; M C Giubellino; P L Tazzari; S Tura
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

10.  Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.

Authors:  H Kubagawa; L B Vogler; J D Capra; M E Conrad; A R Lawton; M D Cooper
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  2 in total

1.  Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.

Authors:  P L Tazzari; M Gobbi; A Dinota; A Bontadini; G Grassi; C Cerato; M Cavo; S Pileri; F Caligaris-Cappio; S Tura
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

2.  Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.

Authors:  F Caligaris-Cappio; L Bergui; L Tesio; G Pizzolo; F Malavasi; M Chilosi; D Campana; B van Camp; G Janossy
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.